置入式输液港在恶性肿瘤治疗中的应用进展

摘要
图/表
参考文献
相关文章 (15)

[1]	Institute for Safe Medication Practice(ISMP).ISMP safe practice guidelines for adult IV push medications[EB/OL].(2015- 07-23).https://www.ismp.org/sites/default/files/attachments/2017-11/ISMP97-Guidelines-071415-3.%20FINAL.pdf
[2]	中国医师协会介入医师分会.植入式给药装置介入专家共识[J].中华医学杂志,2019,99(7):484-490.
[3]	孙红,陈利芬,郭彩霞,等.临床静脉导管维护操作专家共识[J].中华护理杂志,2019,54(9):1334-1342.
[4]	王丹.小儿静脉留置针保留时间的影响因素分析[J].当代护士,2021,28(2):157-160.
[5]	国家卫生和计划生育委员会.《静脉治疗护理技术操作规范》[EB／OL].(2014.12.12)[2016-Il-21].http://www.nhfpc. gov. cn/zhuzhan/index.Shtml.
[6]	谢建梅,王曙红,谭江红.PICC 置管患者人舒适度研究进展[J].齐鲁护理杂志,2016,22(13): 52-53.
[7]	赵超尘.完全植入式静脉输液港经颈内与锁骨下入路对比分析[J].广东医学. 2016,17(s):45-47.
[8]	Ahn S J, Kim H C, Chung J W, et al.Ultrasound and fluoroscopy－guided placement of central venous ports via internal jugular vein: retrospective analysis of 1254 port implantations at a single center[J].Korean J Radiol,2012, 13(3):314-323.
[9]	仇晓霞,超声导引下上臂完全植入式输液港植入临床应用[J].介入放射学杂志, 2017,26(8): 689-694.
[10]	中心静脉通路上海协作组,上海市抗癌协会实体肿瘤聚焦诊疗专委会血管通路专家委员会. 完全植入式输液港上海专家共识(2019)[J],介入放射学杂志,2019,28(12): 1123-1128.
[11]	刘霞,俞娟,高薇.经股静脉植入静脉输液港在晚期肿瘤病人中的临床应用[J].全科护理, 2016,14(6):579-581.
[12]	吴孝红,陈惜遂,张红,等,三种路径植入静脉输液港安全性的Meta分析[J].中华护理杂志,2019,54(10):1551-1558.
[13]	陈凤琴,潘岐作,冯礼浓.经股静脉植入输液港在上腔静脉压迫综合征患者中的应用与护理[J].护理实践与研究,2018,15(4): 115-116.
[14]	刘飞,王影新. 植入式上臂输液港技术的应用进展[J].中国实用护理杂志, 2020,36 (10):796-800.
[15]	刘军,陆游,姜浩,等.双导向技术引导下三种路径植入输液港的对比分析[J].中华医学杂志,2020,100 (17),1332-1335.
[16]	胡素琴,朱红,王桂玲.成人PICC置管术体外测量方法的研究进展[J].护理研究,2015,29(7):2316-2317.
[17]	杜鹏,倪才方,樊宝瑞,等.经颈内静脉植入式输液港导管长度的估算方法[J].介入放射学杂志,2019,28(2):124-127.
[18]	孙尚龙,陈海波,钱一丹,等.经颈内静脉植入完全植入式输液港导管长度的临床研究[J]. 介入放射学杂志,2019,28(12):1167-11701.
[19]	韩娟,李蓉梅.PICC尖端定位测量方法及影响因素的研究进展[J].护理与康复,2017,16(9):941-944.
[20]	Infusion Nurse Society. Infusion Nursing Standards of practice[J]. J Infus Nurs,2016, 39(1s): S47.
[21]	韩真真,刘光,张海军. 经外周中心静脉导管尖端定位技术应用研究进展[J].中国医疗器械杂志,2020,44(1):56-59.
[22]	Dale M, Higgins A, Carolan-Rees G. Sherlock3CG tip confirmation system for placement of peripherally inserted central catheters: a nice medical technology guidance[J]. Appl Health Econ Hea, 2016, 14(1): 41-49.
[23]	中华人民共和国国家卫生和计划生育委员会. 中华人民共和国卫生行业标准—静脉治疗护理技术操作规范,WS/T433[S].2013.
[24]	Infusion Nurses Society. Infusion Therapy Standards of 2016: policies and procedures for infusion therapy[S]. Norwood:Infusion Nurses Society,2016.
[25]	张玉娟, 静脉输液港植入患者在非治疗期间延长维护间隔时间对导管堵塞及感染的影响[J].心电图杂志(电子版),2020,9(1):221.
[26]	Keogh S,Flynn J,Marsh N,et al.Varied flushing frequency and volume to prevent peripheral intravenous catheter failure [J].Trials,2016,17(1):348.
[27]	Di Carlo I, Biffi R. Totally implantable venous access devices[M]. Italia: Springer Verlag, 2012.
[28]	张军平,张鸾.输液港植入术术后切口愈合不良的原因分析[J]. 心电图杂志(电子版), 2020,9( 3): 142-143.
[29]	石思梅,黄雯薏. 830例输液港植入术患者术后伤口的护理及愈合时间观察[J]. 实用临床护理学电子杂志,2019,4(17):57.
[30]	丁伟,周奇,孙飞虎,等,完全植入式静脉输液港术后港体翻转临床分析[J].介入医学杂志,2019,29(3):291-295.
[31]	王岩,付玉芳,杨爱玲,等.植入式静脉输液港注射座翻转的复位及处置[J].军事医学,2019,43(2):158-159.
[32]	Lebeaux D, Fernandez-Hidalgo N, Chauhan A, et al. Management of infections related to totally implantable venous-access ports: challenges and perspectives [J]. Lancet Infect Dis, 2014,14 (2):146-159.
[33]	谢琼,卢咏,方少梅,等.植人式静脉输液港相关性感染预防及管理的最佳证据总结[J].护理学杂志,2020,35(12): 49-53.
[34]	余永刚,朱卉娟,厉周.植入式静脉输液港感染相关影响因素的研究进展[J].中国医药导报,2019,16( 10):41-44.
[35]	鲍秋红,周华,陈茜,等,肺癌化疗合并院内肺部感染的病原茵特点及影响因素[J].中国肺癌杂志,2019,22(12):772-778.
[36]	Zacharioudakis I M,Zervou F N,Arvanitis M,et al.Antimicrobial lock solutions a method to prevent central line.associated bloodstream infections:a meta—analysis of randomized controlled trials[J].Clin Infect Dis,2014,59(12):1741-1749.
[37]	Ling M L, Apisarnthanarak A, Jaggi N, et al. APSIC guide for prevention of Central Line Associated Bloodstream Infections (CLABSI) [J]. Antimicrob Resist Infect Control, 2016, 5: 16.
[38]	Chang Y F, Lo A C, Tsai C H, et al. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis [J]. Palliat Med, 2013, 27(2):185-191.
[39]	Almasi-Sperling V, Hieber S, Lermann J, et al. Femoral placement of totally implantable venous access ports in patients with bilateral breast cancer[J]. Geburtsh Frauenheilk, 2016, 76(1):53-58.
[40]	傅麒宁,吴洲鹏,孙文彦,等.《输液导管相关静脉血栓形成中国专家共识》临床实践推荐[J]. 中国普外基础与临床杂志 2020,27(4):412-418.
[41]	秦朝晖,刘军,李蔚萍.夹闭综合征的诊断和治疗进展[J].老年医学与保健,2019,25(2): 270-276.
[42]	Ma L I, Liu Y, Wang J, et al. Totally implantable venous access port systems and associated complications: a single-institution retrospective analysis of 2996 breast cancer patients [J]. Mol Clin Oncol, 2016, 4(3):456-460.
[43]	黄钰清,赵志莹,陈国连,等.乳腺癌住院患者输液港纤维蛋白鞘形成的危险因素及防治措施[J]. 临床护理杂志,2020,19(2): 75-78.
[44]	胡飞翔,蔡明,淳林,等.输液港在乳腺癌患者化疗中的临床应用[J/CD].中华乳腺病杂志(电子版), 2014,8(1): 59-61.
[45]	Viviani E, Giribono A M, Ferrara D, et al. Chest pain due to pinch-off syndrome: radiological findings and endovascular rescue [J]. Clin Ter, 2016,167(1): 13-15.